Skip to main content

Cellular Oncology

Ausgabe 6/2024

Inhalt (29 Artikel)

Mitochondria in tumor immune surveillance and tumor therapies targeting mitochondria

  • Review

Lvyuan Li, Yi Zhang, Qiling Tang, Chunyu Wu, Mei Yang, Yan Hu, Zhaojian Gong, Lei Shi, Can Guo, Zhaoyang Zeng, Pan Chen, Wei Xiong

Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance

  • Review

Ting Mei, Ting Ye, Dingkun Huang, Yuxiu Xie, Ying Xue, Dongfang Zhou, Weimin Wang, Jing Chen

Role of BRCA1 in glioblastoma etiology

  • Review

Emirhan Harbi, Michael Aschner

Metabolic insights into tumor lymph node metastasis in melanoma

  • Review

Jiayi Huang, Zixu Gao, Jiangying Xuan, Ningyuan Gao, Chuanyuan Wei, Jianying Gu

Circadian system disorder induced by aberrantly activated EFNB2-EPHB2 axis leads to facilitated liver metastasis in gastric cancer

  • Research

Qing Li, Yuxuan Lin, Bo Ni, Haigang Geng, Chaojie Wang, Enhao Zhao, Chunchao Zhu

Clinical value of 18F-FDG PET/CT in patients with newly diagnosed acute leukemia

  • Research

Jiamin Fang, Jie Chen, Xinqi Li, Pengpeng Li, Xiaoyan Liu, Yong He, Fuling Zhou

Tumour cell-released autophagosomes promote lung metastasis by upregulating PD-L1 expression in pulmonary vascular endothelial cells in breast cancer

  • Research

Xu-ru Wang, Xiao-he Zhou, Xiao-tong Sun, Yu-qing Shen, Yu-yang Wu, Cheng-dong Wu, Feng-jiao Zhu, Yi-ting Wei, Jin-peng Chen, Jing Chen, Shi-ya Zheng, Li-xin Wang

Non-glycanated ΔDCN isoform in muscle invasive bladder cancer mediates cancer stemness and gemcitabine resistance

  • Research

Nisha Wu, Jinxiang Wang, Mingming Fan, Yanling Liang, Xiao wei Qi, Fan Deng, Fangyin Zeng

Inhibition of EREG/ErbB/ERK by Astragaloside IV reversed taxol-resistance of non-small cell lung cancer through attenuation of stemness via TGFβ and Hedgehog signal pathway

  • Research

Wenhao Xiu, Yujia Zhang, Dongfang Tang, Sau Har Lee, Rui Zeng, Tingjie Ye, Hua Li, Yanlin Lu, Changtai Qin, Yuxi Yang, Xiaofeng Yan, Xiaoling Wang, Xudong Hu, Maoquan Chu, Zhumei Sun, Wei Xu

USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma

  • Research

Qian Qiao, Jifei Wang, Shuochen Liu, Jiang Chang, Tao Zhou, Changxian Li, Yaodong Zhang, Wangjie Jiang, Yananlan Chen, Xiao Xu, Mingyu Wu, Xiangcheng Li

IRE1α inhibitor reduces cisplatin resistance in ovarian cancer by modulating IRE1α/XBP1 pathway

  • Research

Shiyi Lv, Lin Zhang, Min Wu, Shuangshuang Zhu, Yixue Wang, Layang Liu, Yunxuan Li, Ting Zhang, Yujie Wu, Huang Chen, Mingyao Liu, Zhengfang Yi

TENT5A mediates the cancer-inhibiting effects of EGR1 by suppressing the protein stability of RPL35 in hepatocellular carcinoma

  • Research

Xuejie Min, Fen Lin, Xinge Zhao, Junming Yu, Chao Ge, Saihua Zhang, Xianxian Li, Fangyu Zhao, Taoyang Chen, Hua Tian, Mingxia Yan, Jinjun Li, Hong Li

Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study

  • Research

Ruirui Sun, Yang Gou, Long Pan, Qiang He, Yin Zhou, Yi Luo, Chenrui Wu, Yaowu Zhao, Zixuan Fu, Ping Huang

Correction to: Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study

  • Correction

Ruirui Sun, Yang Gou, Long Pan, Qiang He, Yin Zhou, Yi Luo, Chenrui Wu, Yaowu Zhao, Zixuan Fu, Ping Huang

HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma

  • Research

Qiguang Li, Jie Liu, Chong Zeng, Daogang Qin, Zijian Zhang, Qiaoli Lv, Jingao Li, Wei Huang

Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits

  • Research

Lucie Curylova, Iva Staniczkova Zambo, Jakub Neradil, Michal Kyr, Nicola Jurackova, Sarka Pavlova, Kristyna Polaskova, Peter Mudry, Jaroslav Sterba, Renata Veselska, Jan Skoda

Toxicity profiles of immunochemotherapy for gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis

  • Research

Linghong Wan, Fanxuan Tian, Lei Wang, Yongying Hou, Wenkang Liu, Qin Liu, Dongfeng Chen, Xianfeng Li, Junyv Xiang, Zhong-Yi Qin, Tao Wang, Bijng Mao, Linyu Wu, Lu Hu

Regulation of AUF1 alternative splicing by hnRNPA1 and SRSF2 modulate the sensitivity of ovarian cancer cells to cisplatin

  • Research

Jia-Mei Wang, Ning Liu, Xue-Jing Wei, Fu-Ying Zhao, Chao Li, Hua-Qin Wang, Chuan Liu

Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production

  • Research

Jing Yang, Xuhui Tong, Wei Wang, Xianjun Yu, Jin Xu, Si Shi

RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin

  • Research

Jiangling Duan, Xiuyin Guan, Jiaxin Xue, Jiayu Wang, Zhiwei Wang, Xuan Chen, Wen Jiang, Wannian Sui, Yongfang Song, Tianshu Li, Dewang Rao, Xueyan Wu, Ming Lu

Publisher Correction to: RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin

  • Publisher Correction

Jiangling Duan, Xiuyin Guan, Jiaxin Xue, Jiayu Wang, Zhiwei Wang, Xuan Chen, Wen Jiang, Wannian Sui, Yongfang Song, Tianshu Li, Dewang Rao, Xueyan Wu, Ming Lu

Non-canonical function of PHGDH promotes HCC metastasis by interacting with METTL3

  • Research

Bin Cheng, Jing Ma, Ni Tang, Rui Liu, Pai Peng, Kai Wang

GALNT6 drives lenvatinib resistance in hepatocellular carcinoma through autophagy and cancer-associated fibroblast activation

  • Research

Peiling Zhang, Shiping Chen, Jialiang Cai, Lina Song, Bing Quan, Jinglei Wan, Guiqi Zhu, Biao Wang, Yi Yang, Zhengjun Zhou, Tao Li, Zhi Dai

Retraction Note: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma

  • Retraction Note

Ti-Chun Chan, Cheng-Tang Pan, Hsin-Yu Hsieh, Pichpisith Pierre Vejvisithsakul, Ren-Jie Wei, Bi-Wen Yeh, Wen-Jeng Wu, Lih-Ren Chen, Meng-Shin Shiao, Chien-Feng Li, Yow-Ling Shiue

Neu im Fachgebiet Pathologie

Neuroendokrine Neoplasien

Neuroendokrine Tumoren (NET) sind eine bunte Gruppe von Neoplasien, die von neuroendokrinen Zellen im gesamten Körper ausgehen. Die NET-Diagnose stellt aufgrund ihrer vielfältigen Erscheinungsformen, Morphologie und biologischen Verhaltensweisen …

Arzneimittelreaktionen, die unter die Haut gehen

Medikamentöse Therapien können eine Vielzahl mukokutaner Nebenwirkungen hervorrufen. Dennoch geht das Spektrum exanthematischer Arzneimittelreaktionen weit über das Bild klassischer makulopapulöser Exantheme hinaus. Die Übersicht fasst häufige Präsentationen (außerhalb der allergischen Soforttypreaktionen) zusammen.

Pathologie der Milz

Nach einer Beschreibung der Milzanatomie und Darstellung der diagnostisch wichtigsten immunhistochemischen Färbungen zur Identifizierung der normalen Milzkompartimente werden am Beispiel eines nordafrikanischen Patienten mit rezentem …

Molekular definierte Nierenzellkarzinome 2025

Im Zuge der Überarbeitung der WHO-Klassifikation im Jahr 2022 konnten für mehrere Nierenzellkarzinome (NZK), die sich zuvor nicht eindeutig den bis dahin definierten Tumortypen zuordnen ließen, jedoch gemeinsame morphologische und molekulare …